vs
Side-by-side financial comparison of MID PENN BANCORP INC (MPB) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
MID PENN BANCORP INC is the larger business by last-quarter revenue ($62.0M vs $39.6M, roughly 1.6× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 31.4%, a 4.5% gap on every dollar of revenue. On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs -10.9%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $51.2M). Over the past eight quarters, MID PENN BANCORP INC's revenue compounded faster (21.1% CAGR vs -15.0%).
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
MPB vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.0M | $39.6M |
| Net Profit | $19.4M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 43.6% | 32.5% |
| Net Margin | 31.4% | 35.9% |
| Revenue YoY | 30.8% | -10.9% |
| Net Profit YoY | 47.0% | 117.2% |
| EPS (diluted) | $0.83 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.0M | $39.6M | ||
| Q3 25 | $61.8M | $43.4M | ||
| Q2 25 | $54.3M | $43.4M | ||
| Q1 25 | $47.7M | $47.3M | ||
| Q4 24 | $47.4M | $44.4M | ||
| Q3 24 | $45.3M | $53.1M | ||
| Q2 24 | $44.1M | $53.1M | ||
| Q1 24 | $42.3M | $54.8M |
| Q4 25 | $19.4M | $14.2M | ||
| Q3 25 | $18.3M | $12.8M | ||
| Q2 25 | $4.8M | $2.5M | ||
| Q1 25 | $13.7M | $21.5M | ||
| Q4 24 | $13.2M | $6.5M | ||
| Q3 24 | $12.3M | $2.8M | ||
| Q2 24 | $11.8M | $18.5M | ||
| Q1 24 | $12.1M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 43.6% | 32.5% | ||
| Q3 25 | 39.3% | 36.6% | ||
| Q2 25 | 7.9% | 33.6% | ||
| Q1 25 | 35.2% | 51.1% | ||
| Q4 24 | 34.1% | 10.6% | ||
| Q3 24 | 32.8% | 26.1% | ||
| Q2 24 | 32.4% | 51.4% | ||
| Q1 24 | 34.8% | 44.6% |
| Q4 25 | 31.4% | 35.9% | ||
| Q3 25 | 29.6% | 29.6% | ||
| Q2 25 | 8.8% | 5.7% | ||
| Q1 25 | 28.8% | 45.4% | ||
| Q4 24 | 27.9% | 14.7% | ||
| Q3 24 | 27.1% | 5.3% | ||
| Q2 24 | 26.7% | 34.8% | ||
| Q1 24 | 28.7% | 34.2% |
| Q4 25 | $0.83 | $0.15 | ||
| Q3 25 | $0.79 | $0.12 | ||
| Q2 25 | $0.22 | $0.02 | ||
| Q1 25 | $0.71 | $0.21 | ||
| Q4 24 | $0.72 | $0.05 | ||
| Q3 24 | $0.74 | $0.03 | ||
| Q2 24 | $0.71 | $0.20 | ||
| Q1 24 | $0.73 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $814.1M | $248.3M |
| Total Assets | $6.1B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.1M | ||
| Q3 25 | — | $127.4M | ||
| Q2 25 | — | $152.7M | ||
| Q1 25 | — | $132.1M | ||
| Q4 24 | — | $125.0M | ||
| Q3 24 | — | $137.4M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $814.1M | $248.3M | ||
| Q3 25 | $796.3M | $248.0M | ||
| Q2 25 | $775.7M | $244.6M | ||
| Q1 25 | $667.9M | $226.4M | ||
| Q4 24 | $655.0M | $195.1M | ||
| Q3 24 | $573.1M | $205.0M | ||
| Q2 24 | $559.7M | $8.8M | ||
| Q1 24 | $551.0M | $9.0M |
| Q4 25 | $6.1B | $380.4M | ||
| Q3 25 | $6.3B | $321.4M | ||
| Q2 25 | $6.4B | $315.3M | ||
| Q1 25 | $5.5B | $284.6M | ||
| Q4 24 | $5.5B | $266.1M | ||
| Q3 24 | $5.5B | $296.5M | ||
| Q2 24 | $5.4B | $19.5M | ||
| Q1 24 | $5.3B | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.0M | $52.0M |
| Free Cash FlowOCF − Capex | $71.8M | $51.2M |
| FCF MarginFCF / Revenue | 115.8% | 129.3% |
| Capex IntensityCapex / Revenue | 13.3% | 2.0% |
| Cash ConversionOCF / Net Profit | 4.12× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $132.1M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.0M | $52.0M | ||
| Q3 25 | $26.3M | $-20.9M | ||
| Q2 25 | $29.0M | $-8.3M | ||
| Q1 25 | $11.5M | $1.9M | ||
| Q4 24 | $51.4M | $-7.3M | ||
| Q3 24 | $16.9M | $5.0M | ||
| Q2 24 | $18.0M | $19.2M | ||
| Q1 24 | $12.4M | $3.7M |
| Q4 25 | $71.8M | $51.2M | ||
| Q3 25 | $24.3M | $-20.9M | ||
| Q2 25 | $27.2M | $-8.6M | ||
| Q1 25 | $8.8M | $1.7M | ||
| Q4 24 | $44.5M | $-7.9M | ||
| Q3 24 | $16.8M | $4.6M | ||
| Q2 24 | $17.7M | $18.3M | ||
| Q1 24 | $12.1M | $3.0M |
| Q4 25 | 115.8% | 129.3% | ||
| Q3 25 | 39.4% | -48.3% | ||
| Q2 25 | 50.1% | -19.9% | ||
| Q1 25 | 18.4% | 3.5% | ||
| Q4 24 | 93.8% | -17.8% | ||
| Q3 24 | 37.1% | 8.7% | ||
| Q2 24 | 40.2% | 34.5% | ||
| Q1 24 | 28.5% | 5.4% |
| Q4 25 | 13.3% | 2.0% | ||
| Q3 25 | 3.1% | 0.1% | ||
| Q2 25 | 3.2% | 0.7% | ||
| Q1 25 | 5.7% | 0.5% | ||
| Q4 24 | 14.6% | 1.3% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.7% | 1.6% | ||
| Q1 24 | 0.8% | 1.3% |
| Q4 25 | 4.12× | 3.66× | ||
| Q3 25 | 1.44× | -1.63× | ||
| Q2 25 | 6.08× | -3.39× | ||
| Q1 25 | 0.84× | 0.09× | ||
| Q4 24 | 3.88× | -1.12× | ||
| Q3 24 | 1.37× | 1.77× | ||
| Q2 24 | 1.53× | 1.04× | ||
| Q1 24 | 1.02× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MPB
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
